|
⚲
|
| Three Rivers Pharmaceuticals LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001136392 |
| Sale | 2009-02-16 ($10.0 M Offered, $6.6 M Sold) |
| Fund | |
| Phone | 7247786100 |
| Address | 119 Commonwealth Drive Warrendale, 15086 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Betty Sue Rich | |
| Christine Sheehy | |
| Donald Kerrish | |
| Paul Fagan | |
| Jeffrey Fisher | |
| Patrick Kerrish |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Man FRM CA SPC, on behalf of & for the account of GM-1 SP
✚
|
0.0 | |
|
Mangomint, Inc.
✚
|
0.0 | |
|
Manhattan West Secondaries Fund, LP
✚
|
0.0 | |
|
Mann Paul Michael
✚
|
0.0 | |
|
Maranon Centre Street Partnership LP
✚
|
0.0 | |
|
Marble Capital Fund IV - Co-Invest CE, L.P
✚
|
0.0 | |
|
March 2022, a Series of Emblem 55 Master Series, LLC
✚
|
0.0 | |
|
Marchand Philippe
✚
|
0.0 | |
|
Marchesani Charles J
✚
|
0.0 | |
|
Mandae Technologies Inc
✚
|
0.0 |